These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21220177)

  • 1. Volumetric analysis of the substantia innominata in patients with Parkinson's disease according to cognitive status.
    Choi SH; Jung TM; Lee JE; Lee SK; Sohn YH; Lee PH
    Neurobiol Aging; 2012 Jul; 33(7):1265-72. PubMed ID: 21220177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploratory analysis of neuropsychological and neuroanatomical correlates of progressive mild cognitive impairment in Parkinson's disease.
    Lee JE; Cho KH; Song SK; Kim HJ; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2014 Jan; 85(1):7-16. PubMed ID: 23828835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Substantia innominata: MR findings in Parkinson's disease.
    Oikawa H; Sasaki M; Ehara S; Abe T
    Neuroradiology; 2004 Oct; 46(10):817-21. PubMed ID: 15316699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early-onset mild cognitive impairment in Parkinson's disease: Altered corticopetal cholinergic network.
    Kim I; Shin NY; Yunjin Bak ; Hyu Lee P; Lee SK; Mee Lim S
    Sci Rep; 2017 May; 7(1):2381. PubMed ID: 28539629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.
    Shin J; Choi S; Lee JE; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):315-21. PubMed ID: 22228726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of the substantia innominata volume in patients with Parkinson's disease with dementia, dementia with lewy bodies, and Alzheimer's disease.
    Kim HJ; Lee JE; Shin SJ; Sohn YH; Lee PH
    J Mov Disord; 2011 Oct; 4(2):68-72. PubMed ID: 24868398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalamic volume and related visual recognition are associated with freezing of gait in non-demented patients with Parkinson's disease.
    Sunwoo MK; Cho KH; Hong JY; Lee JE; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1106-9. PubMed ID: 23938134
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis among cognitive profiles and gray matter volume in newly diagnosed Parkinson's disease with mild cognitive impairment.
    Noh SW; Han YH; Mun CW; Chung EJ; Kim EG; Ji KH; Seo JH; Kim SJ
    J Neurol Sci; 2014 Dec; 347(1-2):210-3. PubMed ID: 25451006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson's disease.
    Shin S; Lee JE; Hong JY; Sunwoo MK; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2012 Dec; 83(12):1155-61. PubMed ID: 22933812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain volumetry in Parkinson's disease with and without dementia: where are the differences?
    Lee SH; Kim SS; Tae WS; Lee SY; Lee KU; Jhoo J
    Acta Radiol; 2013 Jun; 54(5):581-6. PubMed ID: 23474765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration.
    Hanganu A; Bedetti C; Jubault T; Gagnon JF; Mejia-Constain B; Degroot C; Lafontaine AL; Chouinard S; Monchi O
    Mov Disord; 2013 Sep; 28(10):1360-9. PubMed ID: 23801590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease.
    Pagonabarraga J; Gómez-Ansón B; Rotger R; Llebaria G; García-Sánchez C; Pascual-Sedano B; Gironell A; Delfino M; Ruscalleda J; Kulisevsky J
    Dement Geriatr Cogn Disord; 2012; 34(5-6):312-8. PubMed ID: 23208306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced substantia innominata volume mediates contributions of microvascular and macrovascular disease to cognitive deficits in Alzheimer's disease.
    Jaswal G; Swardfager W; Gao FQ; Nestor SM; Ganda A; Cogo-Moreira H; Sahlas DJ; Stuss DT; Moody A; Black SE
    Neurobiol Aging; 2018 Jun; 66():23-31. PubMed ID: 29505952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive and Neuroanatomical Correlates in Early Versus Late Onset Parkinson's Disease Dementia.
    Kim Y; Lee D; Cho KH; Lee JJ; Ham JH; Ye BS; Lee SK; Lee JM; Sohn YH; Lee PH
    J Alzheimers Dis; 2017; 55(2):485-495. PubMed ID: 27662310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mild cognitive impairment in the elderly is associated with volume loss of the cholinergic basal forebrain region.
    Muth K; Schönmeyer R; Matura S; Haenschel C; Schröder J; Pantel J
    Biol Psychiatry; 2010 Mar; 67(6):588-91. PubMed ID: 19375072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ventricular enlargement and mild cognitive impairment in early Parkinson's disease.
    Dalaker TO; Zivadinov R; Ramasamy DP; Beyer MK; Alves G; Bronnick KS; Tysnes OB; Aarsland D; Larsen JP
    Mov Disord; 2011 Feb; 26(2):297-301. PubMed ID: 21412836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is encroachment of the carotid termination into the substantia innominata associated with its atrophy and cognition in Alzheimer's disease?
    Gao FQ; Pettersen JA; Bocti C; Nestor SM; Kiss A; Black SE
    Neurobiol Aging; 2013 Jul; 34(7):1807-14. PubMed ID: 23414670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and cortical thinning patterns of subjective cognitive decline in patients with and without Parkinson's disease.
    Hong JY; Yun HJ; Sunwoo MK; Ham JH; Lee JM; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2014 Sep; 20(9):999-1003. PubMed ID: 25001316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.